Rapport Therapeutics, Inc. Common Stock
Rachunek Zysków i Strat
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
| Rok finansowy |
2023 |
2023 |
2023 |
2023 |
2024 |
2024 |
2024 |
2024 |
2025 |
| Kwartał |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
| Data |
2023-03-31 |
2023-06-30 |
2023-09-30 |
2023-12-31 |
2024-03-31 |
2024-06-30 |
2024-09-30 |
2024-12-31 |
2025-03-31 |
| Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Przychód Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Marża brutto |
-inf% |
-inf% |
0.0% |
0.0% |
-inf% |
-inf% |
0.0% |
0.0% |
0.0% |
| Koszty i Wydatki (mln) |
5 |
7 |
10 |
15 |
17 |
21 |
22 |
24 |
0 |
| EBIT (mln) |
-5 |
-7 |
-10 |
-15 |
-17 |
-21 |
-22 |
-24 |
-27 |
| EBIT Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
229.3% |
213.7% |
126.3% |
59.0% |
58.6% |
| EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
nan |
| Przychody fiansowe (mln) |
0 |
0 |
1 |
1 |
2 |
3 |
4 |
4 |
3 |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Amortyzacja (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EBITDA (mln) |
-5 |
-7 |
-10 |
-13 |
-17 |
-21 |
-21 |
-23 |
-27 |
| EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
nan |
| NOPLAT (mln) |
-6 |
-6 |
-9 |
-14 |
-23 |
-18 |
-18 |
-20 |
-24 |
| Podatek (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Zysk Netto (mln) |
-6 |
-6 |
-9 |
-14 |
-23 |
-18 |
-18 |
-20 |
-24 |
| Zysk netto Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
268.8% |
182.7% |
101.4% |
47.8% |
6.1% |
| Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
nan |
| EPS |
-0.17 |
-0.18 |
-0.36 |
0.0 |
-0.64 |
-0.5 |
-0.5 |
-0.1 |
-0.68 |
| EPS (rozwodnione) |
-0.17 |
-0.18 |
-0.36 |
0.0 |
-0.64 |
-0.5 |
-0.5 |
-0.1 |
-0.68 |
| Ilośc akcji (mln) |
35 |
37 |
24 |
0 |
35 |
37 |
35 |
193 |
353 |
| Ważona ilośc akcji (mln) |
35 |
37 |
24 |
0 |
35 |
37 |
35 |
193 |
353 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |